<DOC>
	<DOC>NCT01359930</DOC>
	<brief_summary>The study is to primarily measure safety and interactions between oral doses of Naltrexone/Bupropion and i.v. Methamphetamine.</brief_summary>
	<brief_title>Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study</brief_title>
	<detailed_description />
	<mesh_term>Methamphetamine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Bupropion hydrochloride, naltrexone hydrochoride drug combination</mesh_term>
	<criteria>Are MA experienced but not dependent, males or females aged 21to50 years. Reported use of MA during the past six months without experiencing an adverse consequence plus a life time MA or amphetamine use history of at least four occasions of use. Have a body mass index (BMI) between 18 and 30. Are willing and able to give written consent. Are not currently a subject (including still in the followup period) of another drug research study. Have no medical contraindications determined by the following: an adequate medical history, a physical examination including vital signs, 12lead ECG, hematology, blood chemistry, and urinalysis. Have a negative drug test for barbiturates, benzodiazepines, opiates, cocaine, amphetamines and ethanol at the time of hospital admission (Day 0). Are females who have a negative pregnancy test at hospital admission. Are of either nonchildbearing (tubal ligation or total hysterectomy) or of childbearing potential using one or more of the following barrier methods of contraception: male or female condoms (with/without spermicide), diaphragm (with spermicide) and/or copper containing intrauterine device (with/without spermicide). No other contraceptives are acceptable. Please contact site for more information</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>